DITHROCREAM

This brand name is authorized in Estonia, Ireland, United Kingdom

Active ingredients

The drug DITHROCREAM contains one active pharmaceutical ingredient (API):

1 Dithranol UNII U8CJK0JH5M - ANTHRALIN

Dithranol has been used in the treatment of sub-acute and chronic psoriasis for over 70 years and, during that time it has become established as a safe and effective form of therapy. Its precise mode of action is still to be confirmed, although it has been shown to inhibit DNA replication, cellular respiration and key cellular enzymes eg glucose-6-phosphate dehydrogenase. Read about Dithranol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DITHROCREAM Cream	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D05AC01	Other antipsoriatics for topical use	D Dermatologicals → D05 Antipsoriatics → D05A Antipsoriatics for topical use → D05AC Antracen derivatives
Discover more medicines within D05AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1762905
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 36723
Country: IE	Health Products Regulatory Authority	Identifier(s): 21733, 76260, 76287